These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 17525198)
1. Suppression of established experimental autoimmune uveitis by anti-LFA-1alpha Ab. Ke Y; Sun D; Zhang P; Jiang G; Kaplan HJ; Shao H Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2667-75. PubMed ID: 17525198 [TBL] [Abstract][Full Text] [Related]
2. Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells. Shao H; Fu Y; Liao T; Peng Y; Chen L; Kaplan HJ; Sun D Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):596-603. PubMed ID: 15671287 [TBL] [Abstract][Full Text] [Related]
3. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6. Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802 [TBL] [Abstract][Full Text] [Related]
4. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Peng Y; Han G; Shao H; Wang Y; Kaplan HJ; Sun D Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4153-61. PubMed ID: 17724201 [TBL] [Abstract][Full Text] [Related]
5. Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice. Jiang G; Ke Y; Sun D; Han G; Kaplan HJ; Shao H Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):282-9. PubMed ID: 18172104 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity. Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291 [TBL] [Abstract][Full Text] [Related]
7. Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis. Liao T; Ke Y; Shao WH; Haribabu B; Kaplan HJ; Sun D; Shao H Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1543-9. PubMed ID: 16565390 [TBL] [Abstract][Full Text] [Related]
8. In vitro activation of CD8 interphotoreceptor retinoid-binding protein-specific T cells requires not only antigenic stimulation but also exogenous growth factors. Peng Y; Shao H; Ke Y; Zhang P; Xiang J; Kaplan HJ; Sun D J Immunol; 2006 Apr; 176(8):5006-14. PubMed ID: 16585597 [TBL] [Abstract][Full Text] [Related]
9. Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice. Cortes LM; Mattapallil MJ; Silver PB; Donoso LA; Liou GI; Zhu W; Chan CC; Caspi RR Invest Ophthalmol Vis Sci; 2008 May; 49(5):1946-56. PubMed ID: 18436827 [TBL] [Abstract][Full Text] [Related]
10. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells. Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946 [TBL] [Abstract][Full Text] [Related]
11. Effects of monoclonal antibodies directed at cell surface molecules on murine experimental autoimmune uveoretinitis. Ando K; Fujino Y; Mochizuki M Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):848-54. PubMed ID: 10502060 [TBL] [Abstract][Full Text] [Related]
12. Activation of OX40 prolongs and exacerbates autoimmune experimental uveitis. Wu X; Rosenbaum JT; Adamus G; Zhang GL; Duan J; Weinberg A; Zhang Z Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8520-6. PubMed ID: 21948545 [TBL] [Abstract][Full Text] [Related]
13. Regulation of interphotoreceptor retinoid-binding protein (IRBP)-specific Th1 and Th17 cells in anterior chamber-associated immune deviation (ACAID). Cui Y; Shao H; Sun D; Kaplan HJ Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5811-7. PubMed ID: 19458338 [TBL] [Abstract][Full Text] [Related]
14. Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes. Jiang G; Ke Y; Sun D; Wang Y; Kaplan HJ; Shao H Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4769-76. PubMed ID: 19443727 [TBL] [Abstract][Full Text] [Related]
15. HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas/FasL activation-dependent. Jiang G; Wang Y; Yun J; Hajrasouliha AR; Zhao Y; Sun D; Kaplan HJ; Shao H J Neuroinflammation; 2015 Sep; 12():179. PubMed ID: 26394985 [TBL] [Abstract][Full Text] [Related]
16. Tgf-beta inhibits activation and uveitogenicity of primary but not of fully polarized retinal antigen-specific memory-effector T cells. Xu H; Silver PB; Tarrant TK; Chan CC; Caspi RR Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4805-12. PubMed ID: 14578402 [TBL] [Abstract][Full Text] [Related]
17. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis. Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657 [TBL] [Abstract][Full Text] [Related]
18. Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells. Jiang HR; Muckersie E; Robertson M; Forrester JV Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1598-607. PubMed ID: 12657598 [TBL] [Abstract][Full Text] [Related]
20. Minimally activated CD8 autoreactive T cells specific for IRBP express a high level of Foxp3 and are functionally suppressive. Peng Y; Shao H; Ke Y; Zhang P; Han G; Kaplan HJ; Sun D Invest Ophthalmol Vis Sci; 2007 May; 48(5):2178-84. PubMed ID: 17460277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]